$POM News

POMDOCTOR Plans To Change Ratio Of Adss To Class A Ordinary Shares From Current Ratio Of One ADS Representing One-Sixth Class A Ordinary Share To New Ratio Of One ADS Representing Three Class A Ordinary Shares

Pomdoctor FY EPS $(3.14), Sales $57.187M

Small Chinese Firms Withdraw Wall Street IPO Applications

POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management

Pomdoctor Intends To Accelerate Related Technology Research And Development Adoption Through Its Medical Resources And Strong Compliance Capabilities

POMDOCTOR LIMITED Expands Platform Integration With Online Medical Insurance Coverage Across Major Chinese Cities

Pomdoctor Expands Integration with China's Medical Insurance Systems to Enhance Service Reach

POMDOCTOR LIMITED Announces Receipt of Nasdaq Notice

Pomdoctor Receives Nasdaq Warning After Stock Trades Below $1 for Over a Month

POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies

POMDOCTOR Advances Strategic Collaboration With Domestic Pharmaceutical Companies To Accelerate Growth Of Internet Hospital Business

POM stock has given up its prior gain. POMDOCTOR shares were trading higher. The company reported H1 financial results.

POMDOCTOR shares are trading higher. The company reported H1 financial results.

POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results

Pomdoctor H1 EPS $(1.60), Sales $24.400M

POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option

Should You Buy POM Stock After the PomDoctor IPO?

POMDOCTOR LIMITED Announces Closing of Initial Public Offering

POMDOCTOR LIMITED Announces Pricing of Initial Public Offering

Pomdoctor Shares Halted On Circuit Breaker To The Downside, Stock Now Up 8.50%